Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
PLXS US​

Plexus Corp(PLXS US)

$216.98-3.801.72%Ext:$213.95-3.031.40%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Plexus Corp — Company Profile

Operating globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions, Plexus Corp. and its subsidiaries specialize in delivering advanced electronic manufacturing solutions. The company provides a comprehensive range of services, including design and development, efficient supply chain management, support for new product introductions, and core manufacturing capabilities, alongside essential aftermarket services. These offerings are tailored for businesses in key market segments such as healthcare/life sciences, industrial/commercial, aerospace/defense, and communications. Established in 1979, Plexus Corp. maintains its corporate headquarters in Neenah, Wisconsin.

Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Exchange
UQ
CEO
Todd Kelsey
Headquarters
Neenah, WI, US
IPO Date
Feb 5, 1986
Employees
20,000
Website
www.plexus.com

Key Metrics

Price
$273.13
Market Cap
$7.31B
Revenue (TTM)
$1.16B
Net Income (TTM)
$49.81M
EPS (TTM)
1.86
P/E (TTM)
38.97
P/B (TTM)
4.91
Dividend Yield
0.00%
ROE (TTM)
3.34%
ROA (TTM)
1.48%
Operating Margin
5.31%
Beta
1.15

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Operating globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions, Plexus Corp. and its subsidiaries specialize in delivering advanced electronic manufacturing solutions. The company provides a comprehensive range of services, including design and development, efficient supply chain management, support for new product introductions, and core manufacturing capabilities, alongside essential aftermarket services. These offerings are tailored for businesses in key market segments such as healthcare/life sciences, industrial/commercial, aerospace/defense, and communications. Established in 1979, Plexus Corp. maintains its corporate headquarters in Neenah, Wisconsin.

Website
www.plexus.com
Location
Neenah, WI, US
Phone920 969 6000
Employees20,000
CEOTodd Kelsey
Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
IPO DateFeb 5, 1986

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(2.6K)

Expand
  • 4Statement of changes in beneficial ownership22 Oct
  • 4Statement of changes in beneficial ownership17 Sep
  • 4Statement of changes in beneficial ownership16 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 8-KOther Events24 Aug
  • 4Statement of changes in beneficial ownership20 Aug
  • 144Kelsey Todd P.19 Aug
  • SC 13G/APLEXUS CORP14 Aug
  • 4Statement of changes in beneficial ownership13 Aug
  • 144SCHROCK MICHAEL V11 Aug
  • 10-QQ3ended 4 Jul 20266 Aug
  • 8-KResults of Operations and Financial Condition29 Jul
  • 4Statement of changes in beneficial ownership16 Jul
  • 4Statement of changes in beneficial ownership18 Jun
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)18 Jun
  • 4Statement of changes in beneficial ownership8 Jun
  • 8-KEntry into a Material Definitive Agreement8 Jun
  • 144Running Michael J.5 Jun
  • 4Statement of changes in beneficial ownership4 Jun
  • 144Kelsey Todd P.3 Jun

News

  • Plexus Corp. $PLXS Stock Sold by State of Alaska Department of Revenue20 Oct
  • Plexus Corp. (NASDAQ:PLXS) Stock Has Average Target Price of $276.86 According to Analysts18 Oct
  • Critical Analysis: Plexus (NASDAQ:PLXS) and MultiSensor AI (NASDAQ:MSAI)15 Oct
  • Plexus Sets Fiscal Fourth Quarter and Fiscal Year 2026 Earnings Release Date14 Oct
  • Plexus (PLXS) is a Great Momentum Stock: Should You Buy?6 Oct
  • Reviewing Plexus (NASDAQ:PLXS) & Vontier (NYSE:VNT)28 Sep
  • Comparing 908 Devices (NASDAQ:MASS) & Plexus (NASDAQ:PLXS)12 Sep
  • Plexus (PLXS) Up 1.4% Since Last Earnings Report: Can It Continue?28 Aug
  • Can Plexus (PLXS) Climb 25.22% to Reach the Level Wall Street Analysts Expect?27 Aug
  • Deutsche Bank AG Buys Shares of 30,495 Plexus Corp. $PLXS24 Aug
  • Buy 3 Momentum Anomaly Stocks as Surging Oil Prices Rattle Markets19 Aug
  • Earnings Estimates Rising for Plexus (PLXS): Will It Gain?13 Aug
  • Plexus (PLXS) Is Up 7.56% in One Week: What You Should Know13 Aug
  • These 4 Electronics-Manufacturing Stocks Are Surging, and It's Still Time to Buy12 Aug
  • Plexus Corp. $PLXS Shares Purchased by Amundi6 Aug
  • Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?5 Aug
  • Plexus Q3 Beat, Strong Outlook Clouded by Free Cash Flow Concerns5 Aug
  • Plexus Corp. (NASDAQ:PLXS) Receives Consensus Recommendation of “Moderate Buy” from Analysts4 Aug
  • Plexus Corp. (PLXS) Q3 2026 Earnings Call Transcript1 Aug
  • Plexus Q3 Earnings Call Highlights30 Jul

Mentions in Filings

  • … of AIR to corresponding financial multiples and ratios for the following selected publicly traded companies in the aerospace/defense industry (referred to in this section as the “selected companies”): • Jabil Inc. • <strong>Plexus Corp.</strong> • Albany International Corp. • Ducommun Incorporated • Magellan Aerospace Corporation For each of the selected companies, Kipps calculated enterprise value (defined as equity market capitalization plus total debt, …
    AIR INDUSTRIES GROUPPlexus Corp·S-4/A - REGISTRATION STATEMENT·Q4 26·22 Oct
  • … ding on 31 December 2023, but held in the period from 2018 onwards Argenta Bank- en Verzekeringsgroep Argenta Assuranties Argenta Spaarbank Catholic University of Leuven (audit committee chair) LRD (audit committee chair) <strong>Plexus</strong> University Hospital of Leuven (audit committee chair) Z.org Leuven (audit - committee chair) WDP shareholdings as at 25 March 2024 0 Rik Vandenberghe Anne Leclercq Cynthia Van Hulle Annual accounts Governance Results Perf …
    Warehouses De PauwPlexus Corp·EX-99.8 - CB/A - 2023 ANNUAL REPORT OF WAREHOUSES DE PAUW NV.·Q4 26·9 Oct
  • … r), Fluxys Belgium, De Warande, AZ Sint-Maria-Ziekenhuis Halle, Foundation Helios Argenta Bank- en Verzekeringsgroep, Argenta Assuranties, Argenta Spaarbank, KU Leuven (audit committee chair), LRD (audit committee chair), <strong>Plexus</strong>, UZ Leuven (audit committee chair), Zorg Leuven (audit committee chair) 0 Cynthia Van Hulle Listed companies Miko (audit committee chair) – Non-listed companies Argen-Co, Argenta Bank- en Verzekeringsgroep, Argenta Assura …
    Warehouses De PauwPlexus Corp·EX-99.7 - CB/A - 2024 ANNUAL REPORT OF WAREHOUSES DE PAUW NV.·Q4 26·9 Oct
  • … onwards: KU Leuven (chair audit committee), UZ Leuven (chair audit committee), LRD (chair audit committee), Z.org Leuven (chair audit committee), Argenta Bank- en Verzekeringsgroep, Argenta Assuranties, Argenta Spaarbank, <strong>Plexus</strong> WDP shareholdings as of 30 March 2026: 0 The full biography of each director is available on our website at the address www.wdp.eu. This is WDP Strategy and value creation Performance Results Governance Sustainability Ann …
    Warehouses De PauwPlexus Corp·EX-99.6 - CB/A - 2025 ANNUAL REPORT OF WAREHOUSES DE PAUW NV.·Q4 26·9 Oct
  • EXPAREL is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older, and postsurgical regional analgesia via an interscalene brachial <strong>plexus</strong> block in adults, a sciatic nerve block in the popliteal fossa in adults, and an adductor canal block in adults. The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscal …
    Pacira BioSciences, Inc.Plexus Corp·EX-99.1 - 8-K - Entry into a Material Definitive Agreement·Q4 26·8 Oct
  • EXPAREL is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older, and postsurgical regional analgesia via an interscalene brachial <strong>plexus</strong> block in adults, a sciatic nerve block in the popliteal fossa in adults, and an adductor canal block in adults. The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscal …
    Pacira BioSciences, Inc.Plexus Corp·EX-99.1 - SC TO-C - EXHIBIT 99.1·Q4 26·8 Oct

Key Stats

Trading

Px/Chg 1D$273.13 / +1.06%
Prev Close$242.07
% of 52Wk H78.95%
Avg Volume334.61K
Beta1.15
Mkt Cap7.31B
FD Mkt Cap6.49B

Float

Shrs Out/Float26.76M / 26.38M
Short Float0.03%
Days to Cover2.30
Stock Repurchased$21.04M

Current Valuation

EV7.26B
EV/EBITDA24.46
EV/Sales1.69
P/B4.91
P/S1.70
FCF Yield0.22%
ROE3.34%
ROA1.48%
Current Ratio1.54

Estimates

P/E38.97
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgFeb '23Feb '24Jan '25Feb '26Oct '26
PRICE-BASED RATIOS
Price / Earnings72.0156.2019.3235.12102.67146.72
Price / Sales3.082.520.640.994.996.28
Price / Book Value3.262.592.212.963.634.91
Price / Free Cash Flow79.78-167.0343.5111.5054.33456.58
ENTERPRISE VALUE METRICS
Enterprise Value4,446.43,056.02,901.23,861.35,148.87,264.8
Enterprise Value / Sales3.102.720.690.974.866.24
Enterprise Value / EBITDA45.7539.0111.0616.3472.1590.18
Enterprise Value / EBIT61.1548.9115.0724.3898.87118.51

Financials

Full Financials
Millions USD5Yr CAGR (%)Oct '21Oct '22Sep '23Sep '24Sep '25
INCOME STATEMENT
Revenue4.6%3,368.93,811.44,210.33,960.84,033.0
Gross Income5.9%323.3347.2394.6378.5406.5
EBITDA4.2%235.7236.9262.3236.3277.4
EBIT3.4%174.7174.2192.6158.4199.6
Net Income5.6%138.9138.2139.1111.8172.9
EPS (Diluted)7.1%4.764.864.954.016.26
BALANCE SHEET
Cash & ST Inv3.2%270.2274.8256.2345.1306.8
Total Assets6.2%2,461.93,393.23,321.23,153.83,137.1
Total Liabilities4.1%1,433.72,297.52,106.81,829.01,682.5
Total Shareholder Equity9.1%1,028.21,095.71,214.41,324.81,454.6
CASH FLOW
Net Operating Cash Flow15%142.6-26.2165.8436.5249.2
Cap Ex13.7%-57.1-101.6-104.0-95.2-95.3
Free Cash Flow15.8%85.5-127.961.8341.3154.0

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)217.03
Basic Shares26.76
Market Cap5,806.9
Diluted Shares27.37
Fully Diluted Shares Outstanding27.37
Fully Diluted Market Cap5,939.8
+Consolidated Debt259.9
−In-the-Money Convertible Debt—
+Capital Leases25.8
+Operating Leases—
−Cash & Equivalents-303.1
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value5,763.7

Segment data

Revenue

by Products and services

  • Asia Pacific Segment59%
  • Americas Segment30%
  • Emea Segment11%

Revenue

by Geography

  • Asia Pacific Segment59%
  • Americas Segment30%
  • Emea Segment11%

Related companies

Celestica Inc

CLS US

Flex Ltd.

FLEX US

Jabil Inc

JBL US

Ttm Technologies Inc

TTMI US

Sanmina Corp

SANM US

Benchmark Electronics Inc

BHE US

Bel Fuse Inc /NJ

BELFA US

Cts Corp

CTS US

Kimball Electronics, Inc.

KE US

Nano Dimension Ltd.

NNDM US

Key Tronic Corp

KTCC US

Exro Technologies Inc.

EXROF US